American College of Allergy, Asthma and Immunology (ACAAI)

Important Information About COVID-19 for Those with Asthma

 

Newswise — ARLINGTON HEIGHTS, Ill (March 12, 2020) – The recent pandemic outbreak of COVID-19 is creating concern and uncertainty for many people, especially those who suffer from asthma. The elderly, and anyone with severe asthma, immunodeficiency or other chronic conditions where the immune system may be compromised, are the most susceptible to viral infections in general and must take precautions against COVID-19.

As allergists, we advise all our patients, especially those with asthma, to remain on their medications.  It’s important that your asthma be well controlled, especially now. None of the asthma medications, including inhaled corticosteroids and biologics, have been shown to increase the risk of getting COVID-19. Also, if you become infected with COVID-19, there is no information that being on any of the asthma medications will make it worse. So please stay on all your medications. Contact your allergist if you have any questions, if you find you’re having trouble breathing or your asthma symptoms are becoming more severe.

To date, 80% of cases of COVID-19 are mild and limited in time.  Symptoms include fever, cough and shortness of breath. For now, we are advising those with asthma or who may have immunodeficiency to keep up your treatments. It is important that nebulizers are used and cleaned properly. The most important thing is for your asthma to remain well controlled so you can stay healthy.

The following recommendations from the CDC should be considered:

  • Avoid close contact (less than 6 feet) with people who are sick.
  • Don’t touch your eyes, nose or mouth.
  • Wash your hands often with soap and water for at least 20 seconds.
  • Use an alcohol-based hand sanitizer that contains at least 60% alcohol if soap and water are not available.
  • Use tissues to cover coughs and sneezes, then discard tissue in the trash.
  • Clean/disinfect frequently touched objects and surfaces.
  • IF YOU ARE SICK, STAY AT HOME!

For information about the COVID-19 pandemic, here are links to sites with up-to-date and valuable information:

CDC: www.cdc.gov/COVID-19/2019-ncov/

AAFA: https://community.aafa.org/blog/COVID-19-2019-ncov-flu-what-people-with-asthma-need-to-know

Health.com: Allergies vs. COVID-19: Here’s how to tell the difference

 




Filters close

Showing results

110 of 4146
Newswise: Long-Term Impacts of COVID-19: Your Mental Health
Released: 25-Nov-2020 2:15 PM EST
Long-Term Impacts of COVID-19: Your Mental Health
Cedars-Sinai

The COVID-19 pandemic has shaped more than half a year of our lives, canceling plans, upending livelihoods and causing feelings of grief, stress and anxiety. And Cedars-Sinai mental health experts say the pandemic could be shaping our mental health well into the future.

Released: 25-Nov-2020 12:45 PM EST
SARS-CoV-2 mutations do not appear to increase transmissibility
University College London

None of the mutations currently documented in the SARS-CoV-2 virus appear to increase its transmissibility in humans, according to a study led by UCL researchers.

Newswise: COVID-19 vaccine candidate tested preclinically at UAB nears first clinical test in people
Released: 25-Nov-2020 11:05 AM EST
COVID-19 vaccine candidate tested preclinically at UAB nears first clinical test in people
University of Alabama at Birmingham

Maryland-based Altimmune Inc., a clinical stage biopharmaceutical company, has submitted an Investigational New Drug, or IND, application to the United States Food and Drug Administration to commence a Phase 1 clinical study of its single-dose intranasal COVID-19 vaccine candidate, AdCOVID.

Released: 25-Nov-2020 11:05 AM EST
BIDMC researchers reveal how genetic variations are linked to COVID-19 disease severity
Beth Israel Lahey Health

New research BIDMC-led sheds light on the genetic risk factors that make individuals more or less susceptible to severe COVID-19.

Newswise: blog-pandemic-scenario-planning-lg-feature2.jpg
Released: 25-Nov-2020 11:05 AM EST
Pandemic Ups Game on Scenario Planning in The Arts
Wallace Foundation

Researcher/Author of new toolkit and report seeks to help arts and culture organizations add scenario planning to their strategic toolbox

Released: 25-Nov-2020 10:30 AM EST
Young people's anxiety levels doubled during first COVID-19 lockdown, says study
University of Bristol

The number of young people with anxiety doubled from 13 per cent to 24 per cent, during the early stages of the COVID-19 pandemic and lockdown 1, according to new research from the University of Bristol.

Newswise: 249837_web.jpg
Released: 25-Nov-2020 10:20 AM EST
Tracking COVID-19 trends in hard-hit states
Louisiana State University

Currently, there are over 10 million confirmed cases and more than 240,000 casualties attributed to COVID-19 in the U.S.

Released: 25-Nov-2020 9:55 AM EST
More Health Systems Join National #MaskUp Campaign
Cleveland Clinic

Many more health systems are joining the national #MaskUp campaign encouraging Americans to stop the spread of COVID-19 by following safety guidelines. Over just a few days, another 19 health systems with hundreds of hospitals united with 100 health systems nationwide with hospitals numbering in the thousands. The public service campaign is critical to the health and well-being of all Americans. It is a plea from healthcare professionals everywhere: wear a mask and follow other precautions to save lives and help get our country back on its feet.

Newswise: delaterre_jpeg.jpg
Released: 25-Nov-2020 7:35 AM EST
Warwick scientists design model to predict cellular drug targets against Covid-19
University of Warwick

The covid-19 virus, like all viruses relies on their host for reproduction

access_time Embargo lifts in 2 days
Embargo will expire: 30-Nov-2020 10:00 AM EST Released to reporters: 24-Nov-2020 5:35 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 30-Nov-2020 10:00 AM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.


Showing results

110 of 4146

close
0.97562